Optimization and evaluation of mucoadhesive buccal films loaded with resveratrol

被引:35
作者
Ansari, Mudassir [1 ]
Sadarani, Bhakti [1 ]
Majumdar, Anuradha [1 ]
机构
[1] Bombay Coll Pharm, Dept Pharmacol, Bombay 400098, Maharashtra, India
关键词
Buccal films; Ethyl cellulose; 3(2) full factorial design; HydroxyPropyl cellulose; Mucoadhesion; Resveratrol; DRUG-DELIVERY; FORMULATION; BIOAVAILABILITY; PATCHES; ENCAPSULATION; CHITOSAN; NANOPARTICLES; QUERCETIN; STABILITY; POLYMERS;
D O I
10.1016/j.jddst.2017.12.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Resveratrol, a phytoalexin from grapes, has shown several therapeutic benefits such as anti-inflammatory and chemopreventive effects. There is a need to develop novel methods for delivery of resveratrol since it poses problems such as high first pass metabolism and therefore low oral bioavailability. Drug delivery through buccal mucosa offers novel approach in circumventing hepatic metabolism and providing controlled drug release with a wide scope for application for local or systemic deliveries. The present investigation deals with optimization and evaluation of mucoadhesive buccal films of resveratrol. The mucoadhesive buccal films of resveratrol were prepared by solvent casting method using polymer Hydroxypropyl cellulose (HPC) and Ethyl cellulose (EC). Optimization was achieved using 3(2) full factorial design whereby the effect of HPC (X-1) and EC (X-2) concentrations on mucoadhesive strength (Y-1), swelling (Y-2) and in vitro drug release (Y-3) profile were analyzed. The resulting films were characterized for weight uniformity, thickness, folding endurance, drug content, surface pH, swelling, mucoadhesive strength and in vitro drug release. The optimized formulation comprised of 2% (w/v) HPC and 1% (w/v) EC, exhibited satisfactory mucodhesive strength, swelling and optimum drug release upto 8 h. Histopathology of buccal mucosa treated with optimized buccal films exhibited no signs of mucosal damage.
引用
收藏
页码:278 / 288
页数:11
相关论文
共 61 条
[1]   Bilayered Films Based on Novel Polymer Derivative for Improved Ocular Therapy of Gatifloxacin [J].
Aher, Naval Dinesh ;
Nair, Hema Ajit .
SCIENTIFIC WORLD JOURNAL, 2014,
[2]  
Al-Dhubiab B.E., 2014, DRUG DELIV, V23, P2154
[3]   Formulation and physicochemical characterisation of buccoadhesive films containing ketorolac [J].
Alanazi, F. K. ;
Rahman, A. A. Abdel ;
Mahrous, G. M. ;
Alsarra, I. A. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2007, 17 (03) :183-192
[4]   Administration of resveratrol: What formulation solutions to bioavailability limitations? [J].
Amri, A. ;
Chaumeil, J. C. ;
Sfar, S. ;
Charrueau, C. .
JOURNAL OF CONTROLLED RELEASE, 2012, 158 (02) :182-193
[5]   Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study [J].
Ansari, Khalid A. ;
Vavia, Pradeep R. ;
Trotta, Francesco ;
Cavalli, Roberta .
AAPS PHARMSCITECH, 2011, 12 (01) :279-286
[6]   Solubilization of resveratrol in micellar solutions of different bile acids [J].
Atanackovic, Milica ;
Posa, Mihalj ;
Heinle, Helmut ;
Gojkovic-Bukarica, Ljiljana ;
Cvejic, Jelena .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2009, 72 (01) :148-154
[7]   Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels [J].
Attia, MA ;
El-Gibaly, I ;
Shaltout, SE ;
Fetih, GN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 276 (1-2) :11-28
[8]   Development and evaluation of tamarind seed xyloglucan-based mucoadhesive buccal films of rizatriptan benzoate [J].
Avachat, Amelia M. ;
Gujar, Kishore N. ;
Wagh, Kishor V. .
CARBOHYDRATE POLYMERS, 2013, 91 (02) :537-542
[9]   Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study [J].
Averineni, Ranjith Kumar ;
Sunderajan, Subramanian Ganesa ;
Mutalik, Srinivas ;
Nayak, Usha ;
Shavi, Gopal ;
Armugam, Karthik ;
Meka, Sreenivasa Reddy ;
Pandey, Sureshwar ;
Nayanabhirama, Udupa .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2009, 14 (02) :199-207
[10]   Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy [J].
Bharti, Rashmi ;
Dey, Goutam ;
Banerjee, Indranil ;
Dey, Kaushik Kumar ;
Parida, Sheetal ;
Kumar, B. N. Prashanth ;
Das, Chandan Kanta ;
Pal, Ipsita ;
Mukherjee, Manabendra ;
Misra, Mridula ;
Pradhan, Anjan K. ;
Emdad, Luni ;
Das, Swadesh K. ;
Fisher, Paul B. ;
Mandal, Mahitosh .
CANCER LETTERS, 2017, 388 :292-302